Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.
about
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.An undiagnosed pleural effusion with surprising consequences.Fluoroquinolones in the treatment of tuberculosis: which is best?Identification of promising DNA GyrB inhibitors for Tuberculosis using pharmacophore-based virtual screening, molecular docking and molecular dynamics studies.
P2860
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@ast
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@en
type
label
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@ast
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@en
prefLabel
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@ast
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@en
P2093
P2860
P31
P50
P1476
Protecting the tuberculosis dr ...... ional use of fluoroquinolones.
@en
P2093
Davide Manissero
Emma Huitric
Lia D'Ambrosio
Miranda W Langendam
P2860
P304
P356
10.1183/09031936.00036812
P577
2012-05-31T00:00:00Z
2012-10-01T00:00:00Z